COVALENT CELL SURFACE MODIFICATION OF T CELLS FOR TUMOR-TARGETED DELIVERY OF IMMUNOTHERAPY Ghent University
The tremendous potential of cancer immunotherapy is currently hampered by low response rates in patients due to so-called cold tumors that show low infiltration of innate immune cells as well as by immune-related toxicity as side effects. Therefore, there is an urgent need for more safe immunotherapies that allow for a more target-specific engineering of the immune system. To tackle these issues, the overarching goal of this project is to ...